These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4835108)

  • 1. Mammary tumorigenesis in chemical carcinogen-treated mice. II. Dependence on hormone stimulation for tumorigenesis.
    Medina D
    J Natl Cancer Inst; 1974 Jul; 53(1):223-6. PubMed ID: 4835108
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.
    Medina D
    J Natl Cancer Inst; 1974 Jul; 53(1):213-21. PubMed ID: 4835107
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice.
    Medina D
    J Natl Cancer Inst; 1976 Nov; 57(5):1185-9. PubMed ID: 187796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.
    Warner MR; Warner RL
    J Natl Cancer Inst; 1975 Aug; 55(2):289-98. PubMed ID: 808639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial transplantation of carcinogen-treated mammary nodule outgrowths. 3. Dissociation of carcinogen-induced cell variants by dose and chemical structure of carcinogen.
    Medina D
    J Natl Cancer Inst; 1973 Jun; 50(6):1555-9. PubMed ID: 4717566
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammary tumorigenesis in chemical carcinogen-treated mice. VII. Prolactin and progesterone levels in BALB/c mice.
    Medina D; O'Bryan SB; Warner MR; Sinha YN; VanderLaan WP; McCormack S; Hahn P
    J Natl Cancer Inst; 1977 Jul; 59(1):213-9. PubMed ID: 406413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias.
    Medina D; Warner MR
    J Natl Cancer Inst; 1976 Aug; 57(2):331-7. PubMed ID: 826649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture.
    Lin FK; Banerjee MR; Crump LR
    Cancer Res; 1976 May; 36(5):1607-14. PubMed ID: 178426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical carcinogen-induced alveolar nodules in organ culture of mouse mammary gland.
    Banerjee MR; Wood BG; Washburn LL
    J Natl Cancer Inst; 1974 Nov; 53(5):1387-93. PubMed ID: 4473562
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice.
    Medina D; Stockman G; Griswold D
    Cancer Res; 1974 Oct; 34(10):2663-8. PubMed ID: 4607071
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial transplantation of methylcholanthrene-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1363-70. PubMed ID: 5030953
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme activities in induced and serially transplanted murine mammary adenocarcinomas.
    Abraham S; Bartley J; DeOme KB; Faulkin LJ; Medina D
    J Natl Cancer Inst; 1973 Jul; 51(1):251-6. PubMed ID: 4720875
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphology and progression of preneoplastic changes in methylcholanthrene-induced mouse mammary tumorigenesis.
    Basolo F; Fontanini G; Squartini F
    Tumori; 1985 Feb; 71(1):1-11. PubMed ID: 3984042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.
    Ruppert B; Wei W; Medina D; Heppner GH
    J Natl Cancer Inst; 1978 Oct; 61(4):1165-9. PubMed ID: 100605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary carcinogenesis by 3-methylcholanthrene. IV. Effect of pituitary homograft on mammary-gland growth and tumorigenesis.
    DAO TL
    J Natl Cancer Inst; 1962 Jul; 29():107-25. PubMed ID: 13883501
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of mammary-tumor-virus-free BALB-c mouse mammary nodule outgrowth cells in DNA synthesis to 3-methylcholanthrene tumorigenesis.
    Adamson R; Banerjee MR; Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):899-907. PubMed ID: 5573774
    [No Abstract]   [Full Text] [Related]  

  • 20. MURINE MAMMARY CARCINOMAS INDUCED BY INTRAVAGINAL APPLICATIONS OF METHYLCHOLANTHRENE IN MINIMAL DOSAGES.
    YANG YH; CAMPBELL JS
    Can Med Assoc J; 1964 Nov; 91(20):1061-3. PubMed ID: 14214228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.